Authors
Loading...
Preclinical study demonstrates that recombinant IL-7 restores lymphocyte functions in septic shock patients, highlighting its therapeutic potential for sepsis-induced immune dysfunction.
Venet et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: